USP30 and bladder transitional cell carcinoma: USP30-AS1 was found associated with several cancers, such as colon adenocarcinoma, bladder urothelial carcinoma, glioblastoma, and ovarian cancer (Gao et al., 2020; Sun et al., 2020; Mao et al., 2021; Peng et al., 2022).